Dr. Kaufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 GILMAN DR.
MC 0695, Sanford Consortium
La Jolla, CA 92093Phone+1 858-822-1777
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1999 - 2002- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1996 - 1999
Mayo Clinic College of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2016 - 2025
MN State Medical License 2002 - 2016
WI State Medical License 1997 - 2003- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2009
Publications & Presentations
PubMed
- 338 citationsCardiac Repair in a Porcine Model of Acute Myocardial Infarction with Human Induced Pluripotent Stem Cell-Derived Cardiovascular CellsLei Ye, Ying Hua Chang, Qiang Xiong, Pengyuan Zhang, Liying Zhang
Cell Stem Cell. 2014-12-04 - 128 citationsWnt signaling promotes hematoendothelial cell development from human embryonic stem cellsPetter S. Woll, Julie K. Morris, Matt S. Painschab, Rebecca K. Marcus, Aimee D. Kohn
Blood. 2008-01-01 - 72 citationsInhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class IDan S. Kaufman, Renee A. Schoon, Michael J. Robertson, Paul J. Leibson
Proceedings of the National Academy of Sciences of the United States of America. 1995-07-03
Abstracts/Posters
- iPSC-Derived NK Cells Synergize with T Cells and Anti-PD-1 Antibody to Mediate Durable Anti-Tumor Responses In VivoDan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Deletion of CISH in Human Pluripotent Stem Cell-Derived Natural Killer Cells Enhances Anti-Tumor Activity Via Metabolic ReprogrammingDan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell MalignanciesDan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Treating HCC with Genetically Modified NK-Cell TherapyJuly 19th, 2024- Stem Cell-Derived Therapy Shows Promise Against Treatment-Resistant Liver CancerJuly 10th, 2024
- State Stem Cell Agency Funds Three New UC San Diego ProjectsAugust 25th, 2021
- Join now to see all
Grant Support
- Stem Cell Therapy For Myocardial RepairNational Heart, Lung, And Blood Institute2011–2012
- Osteogenic Repair From Human Pluripotent Stem CellsNational Institute Of Dental &Craniofacial Research2011
- Stem Cell Biology Training ProgramEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
- Midwestern Progenitor Cell ConsortiumNational Heart, Lung, And Blood Institute2009–2011
- Hematopoietic Precursor Development From Human Embryonic Stem (ES) CellsNational Heart, Lung, And Blood Institute2007–2010
- Hematopoietic Precursor Development From Human ES CellsNational Heart, Lung, And Blood Institute2006
- Immunocompromised Mouse CoreNational Cancer Institute2005
- In Vivo Potential Of Human ES Cell-Derived Blood CellsNational Heart, Lung, And Blood Institute2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
